Critical role of Kupffer cells in the management of diet-induced diabetes and obesity

Biochemical and Biophysical Research Communications

Volumn 385, Issue 3, 2009, Pages 351-356

  Neyrinck, Audrey M ^a   Cani, Patrice D ^a   Dewulf, Evelyne M ^a   De Backer, Fabienne ^a   Bindels, Laure B ^a   Delzenne, Nathalie M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Diabetes; Glucose tolerance; Hepatic insulin sensitivity; High fat diet; Insulin resistance; Kupffer cells; Obesity; Steatosis

Indexed keywords

GADOLINIUM CHLORIDE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME PHOSPHORYLATION; FATTY LIVER; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINEMIA; KUPFFER CELL; LIPID DIET; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; DIETARY FATS; GADOLINIUM; GLUCONEOGENESIS; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; KUPFFER CELLS; LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; PROTO-ONCOGENE PROTEINS C-AKT;

MUS;

EID: 67349130130     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.05.070     Document Type: Article

References (25)

1. Schenk S., Saberi M., and Olefsky J.M. Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 118 (2008) 2992-3002
2. Leclercq I.A., Da Silva M.A., Schroyen B., Van H.N., and Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J. Hepatol. 47 (2007) 142-156
3. Utzschneider K.M., and Kahn S.E. Review: the role of insulin resistance in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 91 (2006) 4753-4761
4. Shoelson S.E., Herrero L., and Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 132 (2007) 2169-2180
5. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 115 (2005) 1111-1119
6. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., Waget A., Delmee E., Cousin B., Sulpice T., Chamontin B., Ferrieres J., Tanti J.F., Gibson G.R., Casteilla L., Delzenne N.M., Alessi M.C., and Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007) 1761-1772
7. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192 (1990) 245-261
8. Neyrinck A.M., Gomez C., and Delzenne N.M. Precision-cut liver slices in culture as a tool to assess the physiological involvement of Kupffer cells in hepatic metabolism. Comp. Hepatol. 3 (2004) S45
9. Yang S.Q., Lin H.Z., Lane M.D., Clemens M., and Diehl A.M. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. USA 94 (1997) 2557-2562
10. Diehl A.M. Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am. J. Physiol. Gastrointest. Liver Physiol. 282 (2002) G1-G5
11. Neyrinck A.M., Taper H.S., Gevers V., Declerck B., and Delzenne N.M. Inhibition of Kupffer cell activity induces hepatic triglyceride synthesis in fasted rats, independent of lipopolysaccharide challenge. J. Hepatol. 36 (2002) 466-473
12. Neyrinck A.M., De Wispelaere L.D., Vanhulle V.P., Taper H.S., and Delzenne N.M. Are Kupffer cells involved in the metabolic adaptation of the liver to dietary carbohydrates given after fasting?. Biochim. Biophys. Acta 1475 (2000) 238-244
13. Neyrinck A., Eeckhoudt S.L., Meunier C.J., Pampfer S., Taper H.S., Verbeeck R.K., and Delzenne N. Modulation of paracetamol metabolism by Kupffer cells: a study on rat liver slices. Life Sci. 65 (1999) 2851-2859
14. Ding H., Huang J.A., Tong J., Yu X., and Yu J.P. Influence of Kupffer cells on hepatic signal transduction as demonstrated by second messengers and nuclear transcription factors. World J. Gastroenterol. 9 (2003) 2519-2522
15. Knecht K.T., Adachi Y., Bradford B.U., Iimuro Y., Kadiiska M., Xuang Q.H., and Thurman R.G. Free radical adducts in the bile of rats treated chronically with intragastric alcohol: inhibition by destruction of Kupffer cells. Mol. Pharmacol. 47 (1995) 1028-1034
16. Adachi Y., Bradford B.U., Gao W., Bojes H.K., and Thurman R.G. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 20 (1994) 453-460
17. Neyrinck A.M., Margagliotti S., Gomez C., and Delzenne N.M. Kupffer cell-derived prostaglandin E2 is involved in regulation of lipid synthesis in rat liver tissue. Cell Biochem. Funct. 22 (2004) 327-332
18. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., and Shoelson S.E. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11 (2005) 183-190
19. Odegaard J.I., Ricardo-Gonzalez R.R., Red E.A., Vats D., Morel C.R., Goforth M.H., Subramanian V., Mukundan L., Ferrante A.W., and Chawla A. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab. 7 (2008) 496-507
20. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., Wynshaw-Boris A., Poli G., Olefsky J., and Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11 (2005) 191-198
21. Barthel A., and Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E685-E692
22. Agius L. New hepatic targets for glycaemic control in diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 21 (2007) 587-605
23. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., and Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (2008) 1470-1481
24. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., Gibson G.R., and Delzenne N.M. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50 (2007) 2374-2383
25. Cani P.D., Knauf C., Iglesias M.A., Drucker D.J., Delzenne N.M., and Burcelin R. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like Peptide 1 receptor. Diabetes 55 (2006) 1484-1490